Human anti-TNF antibodies

Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

4241421, 4241451, 4241581, 435335, 53038823, 53038824, C07K 1624

Patent

active

056544073

ABSTRACT:
Human monoclonal antibodies (mAbs) which bind to human TNF.alpha. are disclosed. Autoantibodies of both the IgM and IgG isotypes are disclosed. A preferred human monoclonal antibody is known as B5 (F78-1A10-B5 mAb) and it binds to recombinant human TNF.alpha. (rhTNF.alpha.) in ELISA format with a titer comparable to three high affinity neutralizing mouse mAbs. It also binds to cell surface TNF.alpha. and prevents TNF.alpha. secretion by human monocyte cell lines.

REFERENCES:
Rhein, R., "Another Sepsis Drug Down--Immunex' TNF Receptor,"Biotechnology Newswatch Oct. 4, 1993, McGraw Hill, Publishers., pp. 2-3.
Boyle et al., "A Novel Monoclonal Human IgM Autoantibody Which Binds Recombinant Human and Mouse Tumor Necrosis Factor-.alpha.," Cell. Immunol. 152:556-568, 1993.
Boyle et al., "The B5 Monoclonal Human Autoantibody Binds to Cell Surface TNF.alpha. on Human Lymphoid Cells and Cell Lines and Appears to Recognize a Novel Epitope," Cell. Immunol. 152:569-581, 1993.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Human anti-TNF antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Human anti-TNF antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human anti-TNF antibodies will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1075811

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.